See more : DTE Energy Company JR SUB DB 2017 E (DTW) Income Statement Analysis – Financial Results
Complete financial analysis of Mesa Laboratories, Inc. (MLAB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mesa Laboratories, Inc., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Liaoning Port Co., Ltd. (601880.SS) Income Statement Analysis – Financial Results
- Usha Martin Limited (USHAMART.BO) Income Statement Analysis – Financial Results
- J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO) Income Statement Analysis – Financial Results
- Abdullah Saad Mohammed Abo Moati for Bookstores Company (4191.SR) Income Statement Analysis – Financial Results
- People Co., Ltd. (7865.T) Income Statement Analysis – Financial Results
Mesa Laboratories, Inc. (MLAB)
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 216.19M | 219.08M | 184.34M | 133.94M | 117.69M | 103.14M | 96.18M | 93.67M | 84.66M | 71.33M | 52.72M | 46.44M | 39.62M | 32.83M | 21.93M | 21.54M | 19.56M | 17.24M | 11.58M | 10.04M | 9.13M | 9.08M | 9.04M | 9.10M | 8.66M | 8.10M | 7.90M | 7.80M | 8.10M | 6.60M | 6.20M | 4.40M | 3.80M | 3.50M | 2.80M | 1.10M | 1.00M |
| Cost of Revenue | 82.94M | 85.39M | 75.25M | 46.92M | 52.75M | 42.22M | 41.56M | 40.43M | 33.25M | 27.94M | 21.04M | 17.57M | 16.11M | 13.26M | 8.74M | 7.72M | 6.70M | 6.35M | 4.15M | 3.72M | 3.43M | 3.40M | 3.65M | 3.07M | 2.80M | 2.40M | 2.50M | 2.70M | 2.80M | 2.20M | 2.10M | 1.40M | 1.20M | 1.20M | 1.20M | 400.00K | 400.00K |
| Gross Profit | 133.25M | 133.69M | 109.09M | 87.01M | 64.93M | 60.92M | 54.62M | 53.24M | 51.41M | 43.39M | 31.69M | 28.86M | 23.51M | 19.57M | 13.19M | 13.82M | 12.86M | 10.90M | 7.44M | 6.32M | 5.70M | 5.68M | 5.39M | 6.03M | 5.85M | 5.70M | 5.40M | 5.10M | 5.30M | 4.40M | 4.10M | 3.00M | 2.60M | 2.30M | 1.60M | 700.00K | 600.00K |
| Gross Profit Ratio | 61.64% | 61.02% | 59.18% | 64.97% | 55.17% | 59.06% | 56.79% | 56.84% | 60.73% | 60.83% | 60.10% | 62.16% | 59.35% | 59.61% | 60.17% | 64.16% | 65.74% | 63.19% | 64.21% | 62.94% | 62.44% | 62.59% | 59.61% | 66.30% | 67.62% | 70.37% | 68.35% | 65.38% | 65.43% | 66.67% | 66.13% | 68.18% | 68.42% | 65.71% | 57.14% | 63.64% | 60.00% |
| Research & Development | 19.30M | 20.49M | 15.77M | 10.39M | 6.36M | 3.51M | 3.54M | 4.16M | 3.97M | 3.29M | 2.32M | 2.01M | 1.36M | 1.44M | 669.00K | 636.00K | 532.00K | 392.00K | 358.00K | 358.00K | 332.00K | 259.97K | 289.94K | 308.17K | 281.65K | 200.00K | 300.00K | 300.00K | 300.00K | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 72.87M | 72.44M | 60.31M | 45.70M | 37.83M | 31.30M | 26.26M | 22.81M | 23.62M | 17.06M | 11.46M | 9.12M | 5.42M | 4.58M | 2.54M | 2.52M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 38.63M | 37.44M | 28.31M | 18.48M | 12.91M | 8.26M | 8.82M | 9.96M | 7.50M | 7.18M | 6.12M | 4.63M | 3.91M | 3.69M | 2.62M | 3.05M | 2.85B | 2.77B | 1.88B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 111.49M | 109.88M | 88.62M | 64.18M | 50.74M | 39.56M | 35.08M | 32.77M | 31.12M | 24.23M | 17.58M | 13.75M | 9.33M | 8.26M | 5.16M | 5.57M | 5.27M | 4.84M | 2.97M | 2.49M | 2.12M | 2.24M | 2.16M | 2.40M | 2.39M | 2.20M | 2.10M | 2.10M | 2.30M | 1.80M | 2.30M | 1.60M | 1.30M | 1.20M | 1.00M | 600.00K | 600.00K |
| Other Expenses | 274.53M | -3.71M | -1.13M | 91.00K | 50.00K | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | 350.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| Operating Expenses | 406.55M | 130.37M | 104.39M | 74.66M | 57.14M | 43.06M | 38.62M | 36.93M | 35.09M | 27.53M | 19.90M | 15.76M | 10.68M | 9.70M | 5.83M | 6.21M | 5.80M | 5.24M | 3.33M | 2.85M | 2.45M | 2.50M | 2.45M | 2.71M | 3.01M | 2.60M | 2.60M | 2.60M | 2.90M | 2.50M | 2.50M | 1.70M | 1.40M | 1.40M | 1.10M | 600.00K | 600.00K |
| Cost & Expenses | 488.26M | 215.76M | 179.63M | 121.58M | 109.90M | 85.28M | 80.18M | 77.35M | 68.34M | 55.47M | 40.94M | 33.33M | 26.79M | 22.96M | 14.56M | 13.93M | 12.50M | 11.58M | 7.47M | 6.57M | 5.88M | 5.90M | 6.10M | 5.77M | 5.81M | 5.00M | 5.10M | 5.30M | 5.70M | 4.70M | 4.60M | 3.10M | 2.60M | 2.60M | 2.30M | 1.00M | 1.00M |
| Interest Income | 0.00 | 4.77M | 3.89M | 107.00K | 960.00K | 1.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.00K | 195.00M | 130.00M | 193.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.70M | 3.71M | 3.89M | 8.02M | 5.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 31.57M | 33.13M | 25.07M | 17.47M | 12.87M | 9.47M | 9.47M | 8.74M | 7.17M | 5.66M | 3.84M | 3.43M | 2.22M | 1.84M | 786.00K | 788.00K | 742.00K | 669.00K | 93.00K | 90.00K | 97.00K | 115.35K | 115.09K | 521.69K | 332.59K | 200.00K | 200.00K | 200.00K | 300.00K | 300.00K | 200.00K | 100.00K | 100.00K | 200.00K | 100.00K | 0.00 | 0.00 |
| EBITDA | -238.38M | 36.45M | 29.77M | 12.36M | 8.09M | 18.09M | 9.77M | 25.05M | 23.50M | 21.52M | 15.63M | 16.54M | 14.55M | 11.71M | 8.15M | 8.40M | 7.80M | 6.33M | 4.20M | 3.57M | 3.35M | 3.30M | 3.06M | 3.85M | 3.18M | 3.30M | 3.20M | 2.70M | 2.70M | 2.20M | 1.80M | 1.40M | 1.30M | 1.10M | 600.00K | 100.00K | 0.00 |
| EBITDA Ratio | -110.26% | 1.52% | 2.55% | 9.23% | 6.87% | 34.28% | 31.01% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 39.22% | 36.01% | 33.76% | 38.99% | 39.90% | 36.70% | 36.29% | 35.50% | 36.66% | 36.36% | 33.80% | 43.13% | 36.72% | 37.04% | 35.44% | 33.33% | 32.10% | 33.33% | 29.03% | 29.55% | 31.58% | 31.43% | 21.43% | 9.09% | 0.00% |
| Operating Income | -272.08M | -30.50M | -20.37M | -5.30M | -4.90M | 9.78M | 2.18M | 16.31M | 16.32M | 15.86M | 11.79M | 13.10M | 12.48M | 9.86M | 7.37M | 7.61M | 7.06M | 5.66M | 4.11M | 3.48M | 3.25M | 3.19M | 2.94M | 2.81M | 2.85M | 3.10M | 2.80M | 2.50M | 2.40M | 1.90M | 1.60M | 1.30M | 1.20M | 900.00K | 500.00K | 100.00K | 0.00 |
| Operating Income Ratio | -125.85% | -13.92% | -11.05% | -3.96% | -4.16% | 9.48% | 2.27% | 17.42% | 19.28% | 22.24% | 22.35% | 28.22% | 31.49% | 30.05% | 33.60% | 35.33% | 36.10% | 32.82% | 35.48% | 34.61% | 35.60% | 35.09% | 32.53% | 30.84% | 32.87% | 38.27% | 35.44% | 32.05% | 29.63% | 28.79% | 25.81% | 29.55% | 31.58% | 25.71% | 17.86% | 9.09% | 0.00% |
| Total Other Income/Expenses | -3.57M | -3.71M | -1.13M | -10.06M | -4.06M | -1.16M | -1.88M | -2.02M | -768.00K | -517.00K | 1.32M | -126.00K | -146.00K | -113.00K | 36.00K | 86.00K | 195.00K | 130.00K | 193.00K | 98.00K | 50.00K | 55.16K | 78.51K | 70.96K | 243.83K | 100.00K | 400.00K | 100.00K | 0.00 | -100.00K | -100.00K | 0.00 | 100.00K | 100.00K | 0.00 | 100.00K | 0.00 |
| Income Before Tax | -275.65M | -389.00K | 3.57M | 2.30M | 3.43M | 8.62M | 301.00K | 14.30M | 15.56M | 15.35M | 13.10M | 12.98M | 12.33M | 9.75M | 7.40M | 7.69M | 7.26M | 5.79M | 4.30M | 3.57M | 3.30M | 3.24M | 3.02M | 2.88M | 3.09M | 3.20M | 3.20M | 2.60M | 2.40M | 1.80M | 1.50M | 1.30M | 1.30M | 1.00M | 0.00 | 200.00K | 0.00 |
| Income Before Tax Ratio | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% | 8.36% | 0.31% | 15.26% | 18.37% | 21.52% | 24.85% | 27.95% | 31.13% | 29.71% | 33.76% | 35.73% | 37.10% | 33.57% | 37.15% | 35.58% | 36.15% | 35.69% | 33.40% | 31.62% | 35.69% | 39.51% | 40.51% | 33.33% | 29.63% | 27.27% | 24.19% | 29.55% | 34.21% | 28.57% | 0.00% | 18.18% | 0.00% |
| Income Tax Expense | -21.40M | -1.32M | 1.70M | -971.00K | 2.08M | 1.14M | 3.26M | 3.11M | 4.39M | 5.76M | 4.10M | 4.53M | 4.41M | 3.57M | 2.64M | 2.90M | 2.65M | 1.83M | 1.50M | 1.26M | 1.17M | 1.11M | 989.66K | 1.05M | 982.46K | 1.10M | 1.10M | 900.00K | 800.00K | 600.00K | 500.00K | 400.00K | 400.00K | 100.00K | 100.00K | 100.00K | 0.00 |
| Net Income | -254.25M | 930.00K | 1.87M | 3.27M | 1.35M | 7.48M | -2.96M | 11.18M | 11.17M | 9.58M | 9.00M | 8.45M | 7.92M | 6.18M | 4.77M | 4.79M | 4.61M | 3.96M | 2.81M | 2.31M | 2.13M | 2.13M | 2.03M | 1.83M | 2.11M | 2.10M | 2.10M | 1.70M | 1.60M | 1.20M | 1.00M | 900.00K | 900.00K | 900.00K | 400.00K | 100.00K | 0.00 |
| Net Income Ratio | -117.60% | 0.42% | 1.01% | 2.44% | 1.15% | 7.26% | -3.08% | 11.94% | 13.19% | 13.43% | 17.07% | 18.20% | 19.99% | 18.84% | 21.75% | 22.24% | 23.57% | 22.96% | 24.22% | 23.03% | 23.34% | 23.42% | 22.46% | 20.13% | 24.34% | 25.93% | 26.58% | 21.79% | 19.75% | 18.18% | 16.13% | 20.45% | 23.68% | 25.71% | 14.29% | 9.09% | 0.00% |
| EPS | -47.20 | 0.17 | 0.36 | 0.66 | 0.32 | 1.95 | -0.79 | 3.04 | 3.10 | 2.72 | 2.61 | 2.52 | 2.41 | 1.91 | 1.49 | 1.51 | 1.46 | 1.25 | 0.94 | 0.76 | 0.70 | 0.66 | 0.60 | 0.59 | 0.55 | 0.51 | 0.48 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| EPS Diluted | -47.20 | 0.17 | 0.35 | 0.64 | 0.31 | 1.86 | -0.79 | 2.91 | 2.97 | 2.63 | 2.49 | 2.35 | 2.29 | 1.86 | 1.45 | 1.48 | 1.41 | 1.22 | 0.92 | 0.74 | 0.68 | 0.64 | 0.59 | 0.59 | 0.55 | 0.50 | 0.47 | 0.39 | 0.29 | 0.29 | 0.23 | 0.21 | 0.21 | 0.20 | 0.10 | 0.04 | 0.01 |
| Weighted Avg Shares Out | 5.39M | 5.32M | 5.21M | 4.98M | 4.20M | 3.84M | 3.75M | 3.68M | 3.61M | 3.52M | 3.45M | 3.36M | 3.29M | 3.23M | 3.19M | 3.18M | 3.17M | 3.16M | 2.99M | 3.06M | 3.05M | 3.23M | 3.41M | 3.69M | 3.82M | 4.14M | 4.30M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
| Weighted Avg Shares Out (Dil) | 5.39M | 5.36M | 5.34M | 5.12M | 4.37M | 4.03M | 3.77M | 3.84M | 3.76M | 3.65M | 3.61M | 3.59M | 3.46M | 3.33M | 3.29M | 3.24M | 3.28M | 3.23M | 3.05M | 3.14M | 3.14M | 3.30M | 3.45M | 3.72M | 3.84M | 4.17M | 4.40M | 4.47M | 4.33M | 4.14M | 4.35M | 4.29M | 4.29M | 4.50M | 4.00M | 2.50M | 3.48M |
Infection Control Market overview 2020, In-depth analysis with Impact of COVID-19, Types, Opportunities, Revenue and Forecast 2026
Oct 06, 2020 (Heraldkeepers) -- New York, October 6, 2020: The scope of the report includes a detailed study of Global Infection Control Market with the...
Infection Control Market Research Report with Detailed Analysis 2020 & Forecast to 2026
Oct 05, 2020 (Heraldkeepers) -- New York, October 5, 2020: The scope of the report includes a detailed study of Global Infection Control Market with the...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Given Average Rating of “Hold” by Brokerages
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have been given an average rating of “Hold” by the six brokerages that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two...
Parametric Portfolio Associates LLC Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)
Parametric Portfolio Associates LLC increased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 19.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,246 shares of the...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Balyasny Asset Management LLC
Balyasny Asset Management LLC lowered its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 62.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned...
Mackenzie Financial Corp Sells 750 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)
Mackenzie Financial Corp cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 42.9% in the first quarter, HoldingsChannel.com reports. The fund owned 1,000 shares of the medical instruments supplier’s stock after selling 750 shares during the period. Mackenzie Financial Corp’s...
COVID-19 Impact and Recovery Analysis- Sterilization Monitoring Market 2020-2024 | Increasing Prevalence of HAIs to Boost Growth | Technavio
The Global Sterilization Monitoring Market will grow by $ 259.99 bn during 2020-2024
Mesa Laboratories, Inc. (NASDAQ:MLAB) Announces Quarterly Dividend of $0.16
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced a quarterly dividend on Wednesday, April 1st, Zacks reports. Shareholders of record on Friday, May 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, June 15th. This...
Mesa Laboratories, Inc. (NASDAQ:MLAB) Receives Average Recommendation of "Buy" from Brokerages
Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) have been assigned a consensus rating of “Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, two have given...
Mesa Laboratories (NASDAQ:MLAB) Stock Rating Lowered by ValuEngine
Mesa Laboratories (NASDAQ:MLAB) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Friday, ValuEngine reports. Several other research analysts have also commented on the company. Zacks Investment...
Source: https://incomestatements.info
Category: Stock Reports